Pfizer Bets $480m On CStone And Surging China Immuno-Oncology Market

26% Annual IO Growth Forecast Alluring

 
• By Brian Yang
CSTONE SIGNS ON PFIZER TO COMMERCIALIZE ITS PD-L1 TO CAPTURE CHINA GROWTH • Source: Shutterstock

More from China

More from Focus On Asia